CN101940605A - 一种继木叶总黄酮醇提取物及其医药用途 - Google Patents
一种继木叶总黄酮醇提取物及其医药用途 Download PDFInfo
- Publication number
- CN101940605A CN101940605A CN 201010266366 CN201010266366A CN101940605A CN 101940605 A CN101940605 A CN 101940605A CN 201010266366 CN201010266366 CN 201010266366 CN 201010266366 A CN201010266366 A CN 201010266366A CN 101940605 A CN101940605 A CN 101940605A
- Authority
- CN
- China
- Prior art keywords
- jimuye
- total flavones
- flavones alcohol
- extract
- alcohol extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 84
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 title abstract description 7
- 235000011957 flavonols Nutrition 0.000 title abstract description 7
- 241000906054 Loropetalum Species 0.000 title abstract 6
- 150000007946 flavonol Chemical class 0.000 title abstract 6
- 239000003814 drug Substances 0.000 claims abstract description 42
- 206010008118 cerebral infarction Diseases 0.000 claims abstract description 15
- 206010012689 Diabetic retinopathy Diseases 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 233
- 229930003944 flavone Natural products 0.000 claims description 110
- 150000002213 flavones Chemical class 0.000 claims description 110
- 235000011949 flavones Nutrition 0.000 claims description 110
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 33
- 238000010828 elution Methods 0.000 claims description 21
- 208000026106 cerebrovascular disease Diseases 0.000 claims description 13
- 239000003463 adsorbent Substances 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000011347 resin Substances 0.000 claims description 11
- 229920005989 resin Polymers 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 206010002383 Angina Pectoris Diseases 0.000 claims description 8
- 239000012567 medical material Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000000287 crude extract Substances 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000007902 hard capsule Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 230000028161 membrane depolarization Effects 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 238000007670 refining Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000700159 Rattus Species 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 19
- 210000002216 heart Anatomy 0.000 abstract description 16
- 238000012360 testing method Methods 0.000 abstract description 9
- 201000006474 Brain Ischemia Diseases 0.000 abstract description 7
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract description 7
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 abstract description 6
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 abstract description 6
- 229960001052 streptozocin Drugs 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 210000004165 myocardium Anatomy 0.000 abstract description 5
- 230000003285 pharmacodynamic effect Effects 0.000 abstract description 5
- 210000004351 coronary vessel Anatomy 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000002776 aggregation Effects 0.000 abstract description 2
- 238000004220 aggregation Methods 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 210000001772 blood platelet Anatomy 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 230000002110 toxicologic effect Effects 0.000 abstract 1
- 231100000027 toxicology Toxicity 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 20
- 239000000243 solution Substances 0.000 description 19
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000013641 positive control Substances 0.000 description 10
- 241000218628 Ginkgo Species 0.000 description 8
- 235000011201 Ginkgo Nutrition 0.000 description 8
- 235000008100 Ginkgo biloba Nutrition 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 210000001525 retina Anatomy 0.000 description 8
- 238000010998 test method Methods 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 230000002526 effect on cardiovascular system Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000001291 vacuum drying Methods 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000010412 perfusion Effects 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 208000017442 Retinal disease Diseases 0.000 description 4
- 206010038923 Retinopathy Diseases 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 210000000709 aorta Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 210000001168 carotid artery common Anatomy 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000003810 ethyl acetate extraction Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000004731 jugular vein Anatomy 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000820 toxicity test Toxicity 0.000 description 3
- 238000009602 toxicology test Methods 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010038491 Renal papillary necrosis Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- QGNBTYAQAPLTMX-UHFFFAOYSA-L calcium dobesilate Chemical compound [Ca+2].OC1=CC=C(O)C(S([O-])(=O)=O)=C1.OC1=CC=C(O)C(S([O-])(=O)=O)=C1 QGNBTYAQAPLTMX-UHFFFAOYSA-L 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 229940011964 pentobarbital sodium 30 mg Drugs 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 210000001202 rhombencephalon Anatomy 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000001732 thrombotic effect Effects 0.000 description 2
- 241000270728 Alligator Species 0.000 description 1
- 229920002955 Art silk Polymers 0.000 description 1
- 206010052895 Coronary artery insufficiency Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000142952 Hamamelidaceae Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000906048 Loropetalum chinense Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 101100427174 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) mus-8 gene Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000531807 Psophiidae Species 0.000 description 1
- 206010038669 Respiratory arrest Diseases 0.000 description 1
- 101710104507 Retinochrome Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000007159 enucleation Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000004518 granules dosage form Substances 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 210000003090 iliac artery Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000000534 thyroid cartilage Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102663665A CN101940605B (zh) | 2010-08-30 | 2010-08-30 | 一种继木叶总黄酮醇提取物及其医药用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102663665A CN101940605B (zh) | 2010-08-30 | 2010-08-30 | 一种继木叶总黄酮醇提取物及其医药用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101940605A true CN101940605A (zh) | 2011-01-12 |
CN101940605B CN101940605B (zh) | 2011-09-07 |
Family
ID=43432937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102663665A Active CN101940605B (zh) | 2010-08-30 | 2010-08-30 | 一种继木叶总黄酮醇提取物及其医药用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101940605B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579524A (zh) * | 2012-03-28 | 2012-07-18 | 江西徳宇集团 | 白花檵木提取物在制备愈伤药物中的应用 |
CN102716157A (zh) * | 2012-07-06 | 2012-10-10 | 江西本草天工科技有限责任公司 | 白花檵木总酚类提取物及其制备与应用 |
CN108324603A (zh) * | 2018-04-28 | 2018-07-27 | 烟台新时代健康产业日化有限公司 | 一种含有松花粉提取物的化妆品及其制备工艺 |
CN108926506A (zh) * | 2018-09-27 | 2018-12-04 | 中国农业科学院麻类研究所 | 黄麻叶中黄酮醇类组分的提取方法及其提取物和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101249129A (zh) * | 2008-03-31 | 2008-08-27 | 周小江 | 一种中药提取物的组合物及其医药用途 |
-
2010
- 2010-08-30 CN CN2010102663665A patent/CN101940605B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101249129A (zh) * | 2008-03-31 | 2008-08-27 | 周小江 | 一种中药提取物的组合物及其医药用途 |
Non-Patent Citations (1)
Title |
---|
《化学通报》 20091231 游璐茜等 檵木中槲皮素、山奈酚和杨梅素含量的高效液相色谱法测定 第896-900页 1-8 , 第10期 2 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579524A (zh) * | 2012-03-28 | 2012-07-18 | 江西徳宇集团 | 白花檵木提取物在制备愈伤药物中的应用 |
CN102716157A (zh) * | 2012-07-06 | 2012-10-10 | 江西本草天工科技有限责任公司 | 白花檵木总酚类提取物及其制备与应用 |
CN108324603A (zh) * | 2018-04-28 | 2018-07-27 | 烟台新时代健康产业日化有限公司 | 一种含有松花粉提取物的化妆品及其制备工艺 |
CN108324603B (zh) * | 2018-04-28 | 2020-04-21 | 烟台新时代健康产业日化有限公司 | 一种含有松花粉提取物的化妆品及其制备工艺 |
CN108926506A (zh) * | 2018-09-27 | 2018-12-04 | 中国农业科学院麻类研究所 | 黄麻叶中黄酮醇类组分的提取方法及其提取物和应用 |
CN108926506B (zh) * | 2018-09-27 | 2022-02-25 | 中国农业科学院麻类研究所 | 黄麻叶中黄酮醇类组分的提取方法及其提取物和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101940605B (zh) | 2011-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104208302A (zh) | 一种降血脂的金樱子保健口服液及其制备方法 | |
CN102028700B (zh) | 一种药物组合物及其制备方法 | |
CN1931217B (zh) | 一种由银杏叶与红景天制成的药物组合物 | |
CN101940605B (zh) | 一种继木叶总黄酮醇提取物及其医药用途 | |
CN101744878B (zh) | 丹参水溶性提取物、其制剂及用途 | |
CN102274260A (zh) | 一种三七提取物的药物组合物及其制备方法 | |
CN102319398B (zh) | 一种和血明目中药组合物及其制备方法 | |
CN1935178A (zh) | 银杏叶提取物与淫羊藿提取物的组合物 | |
CN101152223B (zh) | 杨树叶酚类提取物在制备治疗心律失常的药物中的应用 | |
CN101716253B (zh) | 一种活血化淤、益气养阴的中药制剂及其制备方法 | |
CN104587047B (zh) | 一种用于治疗心脑血管疾病的中药组合物 | |
CN101176751B (zh) | 丹参和桂枝的药物组合物 | |
CN104547494A (zh) | 治疗甲亢的中药组合物药酒及制备工艺 | |
CN103784825A (zh) | 一种穿虎痛风合剂 | |
CN109172624A (zh) | 一种治疗缺血性脑卒中的药物组合物及其应用 | |
CN103549072A (zh) | 一种益气护脑茶及其制备方法 | |
CN108478706A (zh) | 一种保护心血管的组合物及其制备方法 | |
CN101176770B (zh) | 银杏叶与蒲黄的药用组合物 | |
CN101716254B (zh) | 一种复方血栓通中药制剂及其制备方法 | |
CN101884660A (zh) | 一种治疗心脑血管疾病的中药组合物及其制法、用途 | |
CN101161268B (zh) | 丹参和蒲黄的药用组合物 | |
CN101884666A (zh) | 一种治疗心脑血管疾病的中药组合物及其制备方法和用途 | |
CN106344634A (zh) | 一种芒果皮提取物及其制备方法和用途 | |
CN101108198B (zh) | 羊藿灯盏药物组合物 | |
CN106729101B (zh) | 一种治疗后循环缺血性脑卒中的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: YAOSHENGTANG (HUNAN) PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHOU XIAOJIANG Effective date: 20111017 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 410007 CHANGSHA, HUNAN PROVINCE TO: 415600 CHANGDE, HUNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20111017 Address after: 415600 Anxiang County Industrial Park, Hunan, Changde Patentee after: Yaoshengtang (Hunan) Pharmaceutical Co., Ltd. Address before: 410007 Hunan province Changsha labor Road No. 61 building 202 Yahua champs Huadu 15 Patentee before: Zhou Xiaojiang |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210113 Address after: 410000 No.3, Longyuan 1st Road, Longping hi tech park, Furong district, Changsha City, Hunan Province Patentee after: HUNAN YAOSHENGTANG TRADITIONAL CHINESE MEDICINE TECHNOLOGY Co.,Ltd. Address before: 415600 Anxiang Industrial Park, Changde City, Hunan Province Patentee before: YAOSHENGTANG (HUNAN) PHARMACEUTICAL Co.,Ltd. |